Mylicongas (Simeticone)

Simeticone acts as a surfactant that lowers the surface tension of gas bubbles in the stomach and intestines. This causes small bubbles to merge into larger ones, which can be passed more readily through belching or flatulence, thereby reducing the feeling of trapped gas.

The appropriate dose of Mylicongas is determined by a prescriber based on the patient’s age, weight, and severity of symptoms. Dosage instructions are provided on the product label and should be followed exactly as directed by a healthcare professional.

Safety of simeticone in pregnancy and lactation has not been definitively established. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mylicongas.

To request Mylicongas, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Mylicongas contains simeticone, the same active ingredient found in many over‑the‑counter gas‑relief products. Compared with antacid‑based remedies, simeticone works mechanically on gas bubbles rather than altering stomach acidity, making it suitable for patients who need symptom relief without affecting pH.

Mylicongas should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mylicongas is taken orally, usually as a chewable tablet or liquid, as directed by the prescribing clinician. It can be taken with or without food, and the dosage form should be swallowed or chewed according to the label instructions.

Serious risks are rare but may include allergic reactions such as rash, itching, swelling, or anaphylaxis. If any signs of a severe hypersensitivity reaction occur, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to simeticone or any of the product’s excipients should avoid Mylicongas. Additionally, it should not be used in infants unless specifically prescribed by a qualified healthcare professional.